SGLT2 Inhibitors and HFpEF: A Promise Fulfilled?
Published: 05 October 2022
Part 1 | Session 1 Welcome and Opening Remarks Shelley Zieroth, Carolyn Lam, Scott Solomon, John JV McMurray, Subodh Verma
This broadcast 'SGLT2 Inhibitors and HFpEF: A Promise Fulfilled?' looks at the latest results from clinical trials studying pharmacotherapies in people with HFpEF, and current and emerging approaches in HFpEF diagnosis.
Dr Shelley Zieroth (St Boniface Hospital, CA) moderates proceedings, and is joined by an outstanding faculty, Prof Carolyn Lam (National Heart Centre, SG), Prof John McMurray (University of Glasgow, UK) Dr Scott Solomon (Brigham and Women's Hospital, US), and Dr Subodh Verma (St. Michael's Hospital, Toronto, CA), for a series of insightful presentations and discussions.
Note, the live version of this session was CME accredited; this on-demand version is not.
- To outline current and emerging approaches in HFpEF diagnosis
- To describe the latest results from clinical trials studying pharmacotherapies in people with HFpEF
- To explain how to practically personalise HFpEF management with established and novel drugs
- Primary Care Physicians
- Diabetes Educators
More from this programme
HFpEF: Unraveling the Mysteries of a Recalcitrant Medical Problem
SGLT2i in the Treatment of HFpEF: Have They Delivered in Clinical Trials?
From DAPA-HF to DELIVER: Does Ejection Fraction Really Matter?
From Paper to Practice - Practical Tips for Physicians
John JV McMurray
Professor of Cardiology
Prof John McMurray is Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. A graduate of Manchester University, Prof McMurray completed postgraduate research at the University of Dundee.
Prof McMurray is a Fellow of the European Society of Cardiology (ESC), American College of Cardiology and American Heart Association as well as the medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences.